EHA 2017 Congress Highlights in Multiple Myeloma

Efficacy of Ixazomib Maintenance in Myeloma Patients (S408) Shaji Kumar, MD – Run Time: 4:40 Begin

Efficacy of Venetoclax in Patients with RRMM (P675) Shaji Kumar, MD – Run Time: 5:14 Begin

Evaluating Long-term Prognosis in MM Patients: Lenalidomide, Maintenance and MRD Philip L. McCarthy, MD – Run Time: 6:33 Begin

The Connect® MM Registry Trial: Results Across the Disease Spectrum Philip L. McCarthy, MD – Run Time: 6:11 Begin

Denosumab for Bone Disease in NDMM Noopur Raje, MD – Run Time: 2:54 Begin

IRd in Newly Diagnosed MM Patients Noopur Raje, MD – Run Time: 3:34 Begin

First-in-Human Multicenter Trial of CAR-T Cells in RRMM Patients Noopur Raje, MD – Run Time: 3:18 Begin

Efficacy of Daratumumab in RRMM: Two- vs Three-Drug Combinations and Cytogenetic Risk Jesús San Miguel, MD – Run Time: 11:35 Begin